81 related articles for article (PubMed ID: 9582522)
1. Cell proliferation studies in primary synovial chondromatosis.
Davis RI; Foster H; Arthur K; Trewin S; Hamilton PW; Biggart DJ
J Pathol; 1998 Jan; 184(1):18-23. PubMed ID: 9582522
[TBL] [Abstract][Full Text] [Related]
2. An immunohistological study of cartilage and synovium in primary synovial chondromatosis.
Apte SS; Athanasou NA
J Pathol; 1992 Mar; 166(3):277-81. PubMed ID: 1381426
[TBL] [Abstract][Full Text] [Related]
3. C-erb B-2 staining in primary synovial chondromatosis: a comparison with other cartilaginous tumours.
Davis RI; Foster H; Biggart DJ
J Pathol; 1996 Aug; 179(4):392-5. PubMed ID: 8869286
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
5. Primary synovial chondromatosis: a reassessment of malignant potential in 155 cases.
McCarthy C; Anderson WJ; Vlychou M; Inagaki Y; Whitwell D; Gibbons CL; Athanasou NA
Skeletal Radiol; 2016 Jun; 45(6):755-62. PubMed ID: 26919862
[TBL] [Abstract][Full Text] [Related]
6. Growth potential of loose bodies: an immunohistochemical examination of primary and secondary synovial osteochondromatosis.
Saotome K; Tamai K; Koguchi Y; Sakai H; Yamaguchi T
J Orthop Res; 1999 Jan; 17(1):73-9. PubMed ID: 10073650
[TBL] [Abstract][Full Text] [Related]
7. Minichromosome maintenance protein (MCM6) in low-grade chondrosarcoma: distinction from enchondroma and identification of progressive tumors.
Helfenstein A; Frahm SO; Krams M; Drescher W; Parwaresch R; Hassenpflug J
Am J Clin Pathol; 2004 Dec; 122(6):912-8. PubMed ID: 15539383
[TBL] [Abstract][Full Text] [Related]
8. [Determination of malignancy of cartilaginous tumors (2). Determination of malignancy by nuclear DNA contents and their distribution patterns in cartilaginous tumors].
Lin CP; Higaki S; Takeyama S; Nakata T; Akai M; Tateishi A; Abe M
Nihon Seikeigeka Gakkai Zasshi; 1983 Jun; 57(6):617-28. PubMed ID: 6619626
[TBL] [Abstract][Full Text] [Related]
9. PAS inclusions, immunoreactive tenascin and proliferative activity in low-grade chondrosarcomas.
Ranty ML; Michot C; Le Pessot F; Hellot MF; Biga N; Dujardin FH; Simonet J; Billerey C; Metayer J
Pathol Res Pract; 2003; 199(1):29-34. PubMed ID: 12650515
[TBL] [Abstract][Full Text] [Related]
10. IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas.
Damato S; Alorjani M; Bonar F; McCarthy SW; Cannon SR; O'Donnell P; Tirabosco R; Amary MF; Flanagan AM
Histopathology; 2012 Jan; 60(2):363-5. PubMed ID: 22074484
[No Abstract] [Full Text] [Related]
11. p53 expression and DNA ploidy of cartilage lesions.
Coughlan B; Feliz A; Ishida T; Czerniak B; Dorfman HD
Hum Pathol; 1995 Jun; 26(6):620-4. PubMed ID: 7774891
[TBL] [Abstract][Full Text] [Related]
12. Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas.
Rozeman LB; Hameetman L; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
J Pathol; 2005 Mar; 205(4):476-82. PubMed ID: 15685701
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
[TBL] [Abstract][Full Text] [Related]
14. Synovial chondromatosis of the hip: a case report and clinicopathologic study.
Gille J; Krueger S; Aberle J; Boehm S; Ince A; Loehr JF
Acta Orthop Belg; 2004 Apr; 70(2):182-8. PubMed ID: 15165024
[TBL] [Abstract][Full Text] [Related]
15. [Recurrent chondromatosis of the metacarpophalangeal joint of the thumb -- differential diagnosis and therapy].
Kriegs-Au G; Müller D
Handchir Mikrochir Plast Chir; 2004 Oct; 36(5):323-7. PubMed ID: 15503265
[TBL] [Abstract][Full Text] [Related]
16. [Giant cell tumor of bone. Morphological, immunohistochemical, morphometric and DNA flow cytometric findings].
Kröber SM; Greschniok A; Böhm P; Kaiserling E
Verh Dtsch Ges Pathol; 1998; 82():279-83. PubMed ID: 10095447
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of angiogenesis and blood vessel maturation in cartilage tumors.
Kalinski T; Sel S; Kouznetsova I; Röpke M; Roessner A
Pathol Res Pract; 2009; 205(5):339-45. PubMed ID: 19157720
[TBL] [Abstract][Full Text] [Related]
18. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
19. DNA cytometry and kinetics of rat urothelial lesions during chemical carcinogenesis.
Palmeira C; Oliveira PA; Arantes-Rodrigues R; Colaço A; De la Cruz PL; Lopes C; Santos L
Oncol Rep; 2009 Jan; 21(1):247-52. PubMed ID: 19082469
[TBL] [Abstract][Full Text] [Related]
20. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
